The DOI matches its OpenAlex record.
A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels
Abstract
OBJECTIVE: To determine whether a glycosylated hemoglobin level can be used in place of an oral glucose tolerance test (OGTT) to diagnose diabetes. DATA SOURCES/STUDY SELECTION: An augmented MEDLINE search was performed to identify all reports from 1966 through June 1994 in which glycosylated hemoglobin levels were measured concurrently with performance of OGTTs in the same study. The corresponding authors were contacted and asked to provide individual data for all subjects tested. A total of 31 investigators representing 34 possible studies responded, and 18 were able to provide us with the data requested. Overall fasting plasma glucose concentrations, 2-hour postdextrose glucose concentrations, and glycosylated hemoglobin levels were available from 11 276 individuals. DATA EXTRACTION: To define normal glucose tolerance, impaired glucose tolerance (IGT), and diabetes, modified World Health Organization criteria were used. DATA SYNTHESIS: An analysis of the methods used for measurement of glycosylated hemoglobin levels revealed that the HbA1c assay showed the least variance in normal subjects. Therefore, only data from the 8984 subjects who had HbA1c levels measured were used. When we used the mean HbA1c level plus 4 SDs as a cutpoint, the sensitivity was 36% and specificity was 100% compared with the results of the OGTT. Because of the lack of agreement between OGTT results and HbA1c levels, models were created to analyze the distribution of HbA1c levels in each study. Using these models, we identified 3 subpopulations. The third subpopulation was likely to represent subjects with diabetes. When we applied an HbA1c level of 7.0% as a cutpoint, the sensitivity was 99.6% for the third subpopulation. When this cutpoint was reapplied to the OGTT results, of those subjects with an HbA1c level of at least 7.0%, 89% had diabetes, 7% had IGT, and 4% were normal. CONCLUSIONS: Although the OGTT is the "gold standard" for diagnosing diabetes, it is known to be poorly reproducible and is often not performed. Not only is use of an HbA1c level to diagnose diabetes more convenient, but therapeutic decisions are based on this value, regardless of the findings on the OGTT. An HbA1c level of 7.0% or higher often requires pharmacological intervention and is most often associated with the diagnosis of diabetes by World Health Organization standards. An HbA1c level below 7.0% would generally be treated with diet and exercise, regardless of the diagnosis of IGT or diabetes by OGTT. Thus, measurement of HbA1c levels may represent a reasonable approach to identifying treatment-requiring diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
Cannon, T. D., Cadenhead, K., Cornblatt, B., Woods, S. W., Addington, J., Walker, E., Seidman, L. J., Perkins, D., Tsuang, M., McGlashan, T., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.3 · Cited by 1,269
Floegel, A., Stefan, N., Yu, Z., Mühlenbruch, K., Drogan, D., Joost, H.-G., Fritsche, A., Häring, H.-U., Hrabě de Angelis, M., Peters, A., et al. (2013) · Diabetes · doi:10.2337/db12-0495 · Cited by 988
Self-citationExercise for type 2 diabetes mellitus
Thomas, D., Elliott, E. J., & Naughton, G. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002968.pub2 · Cited by 728
Surrogate markers of insulin resistance: A review
Singh, B. (2010) · World Journal of Diabetes · doi:10.4239/wjd.v1.i2.36 · Cited by 622
HbA 1c as a screening tool for detection of Type 2 diabetes: a systematic review
Bennett, C. M., Guo, M., & Dharmage, S. C. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02106.x · Cited by 534
A new look at screening and diagnosing diabetes mellitus
Saudek, C. D., Herman, W. H., Sacks, D. B., Bergenstal, R. M., Edelman, D., & Davidson, M. B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2174 · Cited by 432
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
Lindholm, L. H., Ibsen, H., Borch-Johnsen, K., Olsen, M. H., Wachtell, K., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., et al. (2002) · Journal of Hypertension · doi:10.1097/00004872-200209000-00035 · Cited by 392
Preventing progression to first-episode psychosis in early initial prodromal states
Bechdolf, A., Wagner, M., Ruhrmann, S., Harrigan, S., Putzfeld, V., Pukrop, R., Brockhaus-Dumke, A., Berning, J., Janssen, B., Decker, P., et al. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.066357 · Cited by 224
Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women
Pradhan, A. D., Rifai, N., Buring, J. E., & Ridker, P. M. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.03.022 · Cited by 189
Diabetes and Diabetic Retinopathy in a Mexican-American Population
West, S. K., Klein, R., Rodriguez, J., Muñoz, B., Broman, A. T., Sanchez, R., & Snyder, R. (2001) · Diabetes Care · doi:10.2337/diacare.24.7.1204 · Cited by 160
Use of HbA1c in Predicting Progression to Diabetes in French Men and Women
Droumaguet, C., Balkau, B., Simon, D., Caces, E., Tichet, J., Charles, M. A., Eschwege, E., & the DESIR Study Group (2006) · Diabetes Care · doi:10.2337/dc05-2525 · Cited by 159
Perry, R. C., Shankar, R. R., Fineberg, N., McGill, J., & Baron, A. D. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.465 · Cited by 150
Osei, K., Rhinesmith, S., Gaillard, T., & Schuster, D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030686 · Cited by 86
Postchallenge Hyperglycemia in a National Sample of U.S. Adults With Type 2 Diabetes
Erlinger, T. P., & Brancati, F. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1734 · Cited by 83
Macrovascular Risk and Diagnostic Criteria for Type 2 Diabetes
Jesudason, D. R., Dunstan, K., Leong, D., & Wittert, G. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.485 · Cited by 77
Efficacy of aerobic exercise on coronary heart disease risk factors
Kelley, G. A., & Kelley, K. S. (2008) · Preventive Cardiology · doi:10.1111/j.1751-7141.2008.08037.x · Cited by 62
Shimazaki, T., Kadowaki, T., Ohyama, Y., Ohe, K., & Kubota, K. (2007) · Translational research · doi:10.1016/j.trsl.2006.09.008 · Cited by 42
Temporal trends of hemoglobin A1c testing
Pivovarov, R., Albers, D. J., Hripcsak, G., Sepulveda, J. L., & Elhadad, N. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-002592 · Cited by 41
Revisiting the oral glucose tolerance test criterion for the diagnosis of diabetes
Davidson, M. B., Schriger, D. L., Peters, A. L., & Lorber, B. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.08024.x · Cited by 40
Self-citation
Metadata
- Authors
- Peters, A. L.
- Venue
- JAMA
- Publisher
- American Medical Association
- Published
- 1996-10-16
- Volume
- 276
- Issue
- 15
- Pages
- 1246-1252
- ISSN
- 0002-9955 (ISSN-L)
- OpenAlex
- W4300554878
- Cited by
- 289
- References
- 0
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.